A Study of an Investigational Drug for Focal Segmental Glomerulosclerosis (FSGS)
Dr. Gahl and his team at the National Human Genome Research Institute are seeking volunteers aged 18 and older with primary FSGS to participate in a research study on the effects of an experimental drug, ManNAc, on this disease. The study aims to assess the long-term safety and tolerability of ManNAc and determine whether it can reduce protein in the urine of people with FSGS.
Families SHARE: Virtual Reality Study
Research study #IRB002325 is testing a new virtual tool that helps people learn more about their health and family health history. The goal is to build knowledge, skills, and confidence in talking about health within families.
NIAAA Natural History Protocol
To look at a broad range of traits in people who are healthy people and people with alcohol problems. To study them for potential eligibility for other research protocols conducted at the NIH Clinical Center.
Taste and Smell Differences in Obese Versus Non-Obese Individuals
Nicotinic Receptor Genetic Variation and Alcohol Reward